Corporate ActionMay 8, 2026, 04:09 PM
Cytokinetics Raises $760.2M from Public Offering of 11.3M Shares
AI Summary
Cytokinetics, Incorporated completed a public offering of its common stock, raising approximately $760.2 million in net proceeds. The company initially offered 9,859,155 shares at $71.00 per share. The underwriters fully exercised their option to purchase an additional 1,478,873 shares, bringing the total shares sold to 11,338,028.
Key Highlights
- Cytokinetics raised approximately $760.2 million in net proceeds from a public offering.
- The company issued 9,859,155 shares of common stock at $71.00 per share.
- Underwriters fully exercised an option to purchase an additional 1,478,873 shares.
- Total shares sold in the offering amounted to 11,338,028.
- Morgan Stanley, Goldman Sachs, J.P. Morgan, and Jefferies acted as underwriters.
Price Impact
More from CYTK